Eosinophilic esophagitis (EoE) is an eosinophil-rich, TH 2 antigen–mediated disease of
increasing pediatric and adult worldwide prevalence. Diagnosis requires greater than or …

Eosinophilic esophagitis (EoE) is a new disease. It is caused by a T-helper type 2 cell
response to food antigens in contact with the esophageal mucosa. Although no single …

Background Empirical elimination diets are effective for achieving histological remission in
eosinophilic oesophagitis, but randomised trials comparing diet therapies are lacking. We …

Background & Aims Eosinophilic esophagitis (EoE) is an allergen-mediated inflammatory
disease with no approved treatment in the United States. Dupilumab, a VelocImmune …

Background Eosinophilic oesophagitis (EoE) is an increasingly common cause of dysphagia
in both children and adults, as well as one of the most prevalent oesophageal diseases with …

Background & Aims Swallowed topical-acting corticosteroids are recommended as first-line
therapy for eosinophilic esophagitis (EoE). Asthma medications not optimized for …

Endoscopy plays a critical role in caring for and evaluating the patient with eosinophilic
esophagitis (EoE). Endoscopy is essential for diagnosis, assessment of response to therapy …

Background & Aims Disease activity and severity of eosinophilic esophagitis (EoE) dictate
therapeutic options and management, but the decision-making process for determining …

Background & Aims Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder.
Swallowed topical-acting corticosteroids are effective in bringing active EoE into remission …

Esophageal symptoms are common and may indicate the presence of gastroesophageal
reflux disease (GERD), structural processes, motor dysfunction, behavioral conditions, or …